"Cholinergic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.
| Descriptor ID |
D018678
|
| MeSH Number(s) |
D27.505.519.625.120 D27.505.696.577.120
|
| Concept/Terms |
Cholinergic Agents- Cholinergic Agents
- Agents, Cholinergic
- Cholinergics
- Acetylcholine Agents
- Agents, Acetylcholine
- Cholinergic Drugs
- Drugs, Cholinergic
Nicotinic Effect- Nicotinic Effect
- Effect, Nicotinic
- Nicotinic Effects
- Effects, Nicotinic
Cholinergic Effect- Cholinergic Effect
- Effect, Cholinergic
- Cholinergic Effects
- Effects, Cholinergic
Muscarinic Effect- Muscarinic Effect
- Effect, Muscarinic
- Muscarinic Effects
- Effects, Muscarinic
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Agents".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Agents".
This graph shows the total number of publications written about "Cholinergic Agents" by people in this website by year, and whether "Cholinergic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholinergic Agents" by people in Profiles.
-
Cholinergic Basal Forebrain Connectivity to the Basolateral Amygdala Modulates Food Intake. eNeuro. 2024 Mar; 11(3).
-
Sleep Deficits Inter-Link Lower Basal Forebrain-Posterior Cingulate Connectivity and Perceived Stress and Anxiety Bidirectionally in Young Men. Int J Neuropsychopharmacol. 2023 Dec 18; 26(12):879-889.
-
Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression. PLoS One. 2022; 17(6):e0269618.
-
New agents and perspectives in the pharmacological treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2021 03 02; 106:110157.
-
Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia. J Cachexia Sarcopenia Muscle. 2020 12; 11(6):1487-1500.
-
Pupil fluctuations track rapid changes in adrenergic and cholinergic activity in cortex. Nat Commun. 2016 11 08; 7:13289.
-
Muscarinic receptor subtypes differentially control synaptic input and excitability of cerebellum-projecting medial vestibular nucleus neurons. J Neurochem. 2016 Apr; 137(2):226-39.
-
Neuronal nicotinic acetylcholine receptors as drug targets. Expert Opin Ther Targets. 2004 Apr; 8(2):61-4.
-
Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats. Brain Res. 2003 Mar 07; 965(1-2):67-74.
-
Spinal endogenous acetylcholine contributes to the analgesic effect of systemic morphine in rats. Anesthesiology. 2001 Aug; 95(2):525-30.